CCT3 acts as upstream of YAP and TFCP2 to be a potential target and tumor biomarker in liver cancer

ABSTRACT: Recently, we've reported that pro-tumorigenic roles of YAP in liver cancer are indispensable of TFCP2 act as upstream to simultaneously control YAP.The aim of this study is to uncover such proteins and evaluate whether the candidates are potential YAP-associated therapeutic target and diagnostic marker Via mass spectrometry, CCT3 was identified to co-interact with YAP and TFCP2, and importantly.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Hepatocyte, Liver

DISEASE(S): Liver Cancer

SUBMITTER: YA LIU  

LAB HEAD: Fenyong Sun

PROVIDER: PXD013143 | Pride | 2019-09-11

REPOSITORIES: Pride